M

Magellan Health Inc
F:MAH1

Watchlist Manager
Magellan Health Inc
F:MAH1
Watchlist
Price: 83.5 EUR Market Closed
Market Cap: €2.2B

EV/EBIT

38.5
Current
1%
More Expensive
vs 3-y average of 38.1

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
38.5
=
Enterprise Value
€1.9B
/
EBIT
$49.6m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
38.5
=
Enterprise Value
€1.9B
/
EBIT
$49.6m

Valuation Scenarios

Magellan Health Inc is trading above its 3-year average

If EV/EBIT returns to its 3-Year Average (38.1), the stock would be worth €82.62 (1% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-50%
Maximum Upside
No Upside Scenarios
Average Downside
25%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 38.5 €83.5
0%
3-Year Average 38.1 €82.62
-1%
5-Year Average 38.2 €82.83
-1%
Industry Average 19.2 €41.78
-50%
Country Average 19.6 €42.59
-49%

Forward EV/EBIT
Today’s price vs future ebit

Not enough data available to calculate forward EV/EBIT

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
US
Magellan Health Inc
F:MAH1
2.2B EUR 38.5 8.5
US
UnitedHealth Group Inc
NYSE:UNH
320.2B USD 0 26.6
US
Anthem Inc
LSE:0HG8
85.8B USD 0 15.2
US
Elevance Health Inc
NYSE:ELV
72.4B USD 0 12.8
US
Humana Inc
NYSE:HUM
26.2B USD 0 22.1
US
Centene Corp
NYSE:CNC
19.1B USD 0 -2.9
US
Molina Healthcare Inc
NYSE:MOH
7.8B USD 4.6 16.5
US
Healthequity Inc
NASDAQ:HQY
7B USD 23.2 32.7
BR
Odontoprev SA
BOVESPA:ODPV3
8.5B BRL 10.5 14.4
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 12 25.2
US
Clover Health Investments Corp
NASDAQ:CLOV
1.3B USD -13.8 -15.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
M
Magellan Health Inc
F:MAH1
Average EV/EBIT: 17.8
38.5
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
Not Available N/A N/A
US
A
Anthem Inc
LSE:0HG8
Not Available N/A N/A
US
Elevance Health Inc
NYSE:ELV
Not Available N/A N/A
US
Humana Inc
NYSE:HUM
Not Available N/A N/A
US
Centene Corp
NYSE:CNC
Not Available N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
4.6
10%
0.5
US
Healthequity Inc
NASDAQ:HQY
23.2
N/A N/A
BR
Odontoprev SA
BOVESPA:ODPV3
10.5
4%
2.6
US
Progyny Inc
NASDAQ:PGNY
12
47%
0.3
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -13.8 N/A N/A
P/E Multiple
Earnings Growth PEG
US
M
Magellan Health Inc
F:MAH1
Average P/E: 19.3
8.5
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
26.6
22%
1.2
US
A
Anthem Inc
LSE:0HG8
15.2
10%
1.5
US
Elevance Health Inc
NYSE:ELV
12.8
10%
1.3
US
Humana Inc
NYSE:HUM
22.1
38%
0.6
US
Centene Corp
NYSE:CNC
Negative Multiple: -2.9 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
16.5
14%
1.2
US
Healthequity Inc
NASDAQ:HQY
32.7
35%
0.9
BR
Odontoprev SA
BOVESPA:ODPV3
14.4
4%
3.6
US
Progyny Inc
NASDAQ:PGNY
25.2
35%
0.7
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -15.2 N/A N/A

Market Distribution

Higher than 82% of companies in the United States of America
Percentile
82st
Based on 8 638 companies
82st percentile
38.5
Low
0 — 13.6
Typical Range
13.6 — 27.8
High
27.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.6
Median 19.6
70th Percentile 27.8
Max 1 826 183.2

Magellan Health Inc
Glance View

Market Cap
2.2B EUR
Industry
Health Care

In the world of healthcare innovation, Magellan Health Inc. has carved a notable niche, presenting a fresh compass in navigating complex healthcare systems. Founded with a keen focus on specialized management in the healthcare industry, Magellan Health has grown into a formidable player by providing comprehensive solutions in behavioral health, specialty healthcare, and pharmacy management. The company's journey is centered around bridging gaps within the healthcare system, offering services that address mental health and substance abuse issues, emphasizing its commitment to fostering holistic well-being. By managing these critical areas, Magellan partners with payers, providers, and public sector agencies, effectively orchestrating a network that alleviates the burden of mental health challenges and optimizes patient outcomes across the board. At its core, Magellan's financial engine hums through its innovative integration of managed care programs and technology-driven solutions. It generates revenue by offering tailored solutions that help reduce costs while improving access and outcomes. Through a mix of managed care plans for specialty populations and cutting-edge digital platforms, Magellan enhances the delivery of healthcare services, ensuring they reach those who need them most. The company's business model thrives on performance-based contracts and management fees, where success is measured by its ability to improve health care quality and efficiency. By continuously investing in technology and analytics, Magellan Health not only advances its core mission but also sustains a robust economic model that remains resilient amid evolving health sector dynamics.

MAH1 Intrinsic Value
Not Available
M
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett